Navigation Links
Implantable Defibrillators May Not Help Women With Heart Failure
Date:9/14/2009

Analysis of previous research found little benefit for female patients

MONDAY, Sept. 14 (HealthDay News) -- Widely used implantable cardioverter-defibrillators may not actually help women with advanced heart failure.

A new analysis turns up no evidence that the devices, used to detect and then correct abnormal heart rhythms, actually lowered the risk of death among female patients, despite the fact that this is routine therapy for all patients with heart failure.

"We do not know of the benefits of defibrillators when used as primary prevention," said Dr. Christian Machado, senior author of a paper appearing in the Sept. 14 issue of the Archives of Internal Medicine. "We just do not know how much women benefit from this therapy."

Yet, according to an accompanying editorial, 30 percent of people getting implantable cardioverter-defibrillators, also called ICDs, are women.

In fact, there are even guidelines supporting the practice, said Machado, who is director of electrophysiology at Providence Hospital Heart Institute, in Southfield, Mich.

ICDs are intended to prevent sudden cardiac death in heart failure patients, who have a high risk for such an event. And while clinical trials do support the practice, those trials tend to be biased towards men.

Here, a search of medical literature databases turned up only five relevant randomized clinical trials between 1950 and 2008. The trials involved a total of 934 women and 3,810 men, a clear indication that women are underrepresented in this type of study even though women make up almost half of the 5.3 million Americans who have heart failure.

None of the studies on their own showed any survival advantage for women of having a defibrillator implanted, nor did the combined data show any benefit.

But there was a reduction in death rates for men in each trial, as well as when the results were pooled together.

"We need to find a way to study more women in order to be able to identify what subgroups truly benefit from this therapy," Machado said.

But that could be difficult. Given that current guidelines recommend the use of ICDs, it would be unethical to propose a trial that randomized some women to go without one, Machado explained.

And this data is certainly not likely to change cardiac care procedures. "I don't think this is going to change anyone's practice," said Dr. Seth Keller, associate director of cardiac electrophysiology at Lenox Hill Hospital in New York City. "Practice guidelines are pretty well-established in terms of ICDs. But this does raise a lot of questions."

"If it is true that women don't benefit from primary prevention with ICDs, then why not?" he added.

Machado speculated that reasons for women deriving different or less benefit from ICDs could range from different anatomy to hormonal factors to how women's bodies use calcium.

"I'm sure there's more than one factor leading to such a less dramatic benefit in women from this therapy," he said.

In fact, the devices might even cause harm. The editorial referenced one analysis that found that women have a 70 percent greater risk of problems after receiving an ICD than men.

"Let's question the dogma," Machado said. "Let's figure out how to change our recommendations."

But one expert urged caution.

Dr. Wojciech Zareba, director of the Heart Research Follow-Up Program at the University of Rochester Medical Center, felt that this meta-analysis, along with most papers in this form, was fraught with methodological problems that weakened the validity of the findings.

"I believe that we don't have evidence at this moment which would preclude using ICDs in women," Zareba said. "This is unfortunately only stirring the water and doesn't provide any useful clues."

More information

The American Heart Association has more on women and heart disease.



SOURCES: Christian Machado, M.D., director, electrophysiology, Providence Hospital Heart Institute, Southfield, Mich.; Seth Keller, M.D., associate director, cardiac electrophysiology, Lenox Hill Hospital, New York City; Wojciech Zareba, M.D., director, Heart Research Follow-up Program, University of Rochester Medical Center, Rochester, N.Y.; Sept. 14, 2009, Archives of Internal Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Implantable device designed to detect, stop seizures under study at MCG
2. GrantAdler Shipping Novel Implantable Vascular Access Port
3. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
4. EaglePicher Technologies Introduces First Implantable Medical Cell Designed Specifically for Monitoring Applications
5. Implantable medical devices may expose patients to security, privacy risks; solutions suggested
6. Northwestern Memorial trials implantable device to manage congestive heart failure symptoms
7. Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
8. Long-Term Results of VisionCares Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
9. MP3 headphones interfere with implantable defibrillators, pacemakers
10. Implantable monitor may help in managing diastolic heart failure
11. Access MediQuip and WellPoint Finalize First National Contract for Implantable Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Implantable Defibrillators May Not Help Women With Heart Failure
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/27/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology: